Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-01-17
1987-04-28
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 2, 514512, 514533, 514570, 514571, 514595, 514603, 514620, 260402S, 260404, 548533, 549492, 549494, 558240, 558243, 558248, 558254, 558276, 558415, 560 12, 560 13, 560 16, 560 17, 560 22, 560 29, 560 30, 560 33, 560 34, 560 38, 560 39, 560 43, 562426, 562429, 562430, 562431, 562437, 562439, 562443, 562444, 562449, 562450, 562452, 564 47, 564 48, 564 49, 564 50, 564 52, 564155, 564157, 564158, A61K 31265, A61K 3134, C07C153017, C07D30754
Patent
active
046615156
ABSTRACT:
Novel compounds possessing both angiotensin enzyme inhibitory activity and diuretic activity are disclosed. The compounds are represented by the general formula ##STR1## in which X is ##STR2## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are hydrogen, alkyl, alkenyl, alkynyl, phenyl-alkyl, and cycloalkyl, and may be the same or different; n is an integer from 0 to 4 inclusive; M is alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, polycycloalkyl, polycycloalkyl-alkyl, aryl, aralkyl, heteroaryl, heteroaryl-alkyl, hetero-cyloalkyl, hetero-cycloalkyl-alkyl, fused aryl-cycloalkyl, fused aryl-cycloalkyl-alkyl, fused heteroaryl-cycloalkyl, fused heteroaryl-cycloalkyl-alkyl, alkoxyalkyl, alkylthioalkyl, alkylamino-alkyl, or dialkylaminoalkyl, or M and R.sub.6 taken together with the nitrogen to which M is bonded and the carbon to which R.sub.6 is bonded form a saturated unsubstituted heterocyclic group containing 3 or 4 ring carbon atoms; Y is hydroxy, alkoxy, amino, or substituted amino, aminoalkanoyl, aryloxy, aminoalkoxy, or hydroxyalkoxy; Z.sub.1 and Z.sub.2 each is a chemical bond, the group X.sub.3 --(CH.sub.2).sub.m, an amino acid group or the group X.sub.3 --(CH.sub.2).sub.m --X.sub.3 wherein X.sub.3 is oxygen, sulfur or NH and m is an integer from 0 to 4 inclusive; A and B each is the same as R.sub.1 or halogen, trifluoromethyl, OR.sub.1, NO.sub.2, NR.sub.1 R.sub.2, SO.sub.2 NH.sub.2, CN, SR.sub.1, SOR.sub.1, SO.sub.2 R.sub.1, CONR.sub.1 R.sub.2, COOR.sub.1 ; C is hydrogen alkyl, heteroallyl, amino, --CR.sub.1 .dbd.CR.sub.2 --, ##STR3## aminoalkyl, furfurylmethylamino, aminoaryl or aminobenzyl; X.sub.1 and X.sub.2 are each S, SO, SO.sub.2, NR.sub.1, O, chemical bond, (CR.sub.9 R.sub.10).sub.m, --CR.sub.9 .dbd.CR.sub.10 --, and CHOH, with the proviso that at least one of X.sub.1 and X.sub.2 be (CR.sub.9 R.sub.10).sub.m, wherein R.sub.9 and R.sub.10 are each hydrogen or lower alkyl, and m is an integer from 1 to 5; Ar is a divalent arylene or heteroarylene; and R.sub.7 and R.sub.8 are each hydrogen, alkyl, halo, cyano, hydroxy, alkoxy, amino, alkylamino, dialkylamino, mercapto, alkylmercapto, nitro, trifluoromethyl, carboxy, carbalkoxy, COY and NHCONHR.sub.1 wherein R.sub.1 and Y are as hereindefined; and pharmaceutically-acceptable salts thereof.
REFERENCES:
patent: 4046889 (1977-09-01), Ondetti et al.
patent: 4053651 (1977-10-01), Ondetti et al.
patent: 4256761 (1981-03-01), Suh et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4431644 (1984-02-01), Smith et al.
patent: 4431645 (1984-02-01), Smith et al.
patent: 4450275 (1984-05-01), Arimura et al.
patent: 4482725 (1984-11-01), Ondetti et al.
patent: 4483861 (1984-11-01), Iwao et al.
patent: 4496578 (1985-01-01), Iwao et al.
Ondetti et al., Chemical Abstracts, vol. 96 (1982) 1433246 of French Patent 2,479,827 (10-9-81).
Iwao et al., Chemical Abstracts, vol. 93 (1980) 204627g of Ger. Offen. 2,944,037 (5-8-80).
Arimura et al., Derwent of Belgium Pat. No. 879,158 (2-1-80).
Neiss Edward S.
Piwinski John J.
Suh John T.
Raymond Richard L.
USV Pharmaceutical Corporation
LandOfFree
Compounds having angiotensin converting enzyme inhibitory activi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having angiotensin converting enzyme inhibitory activi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having angiotensin converting enzyme inhibitory activi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-477649